메뉴 건너뛰기




Volumn 61, Issue 5, 2013, Pages 580-581

Are all clinical trial sites created equal?

Author keywords

acute heart failure; clinical trials; quality of care and outcomes assessment

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; INOTROPIC AGENT; TOLVAPTAN;

EID: 84873085286     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.10.024     Document Type: Editorial
Times cited : (9)

References (14)
  • 1
    • 60849106348 scopus 로고    scopus 로고
    • Ethical and scientific implications of the globalization of clinical research
    • S.W. Glickman, J.G. McHutchison, E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
    • (2009) N Engl J Med , vol.360 , pp. 816-823
    • Glickman, S.W.1    McHutchison, J.G.2    Peterson, E.D.3
  • 2
    • 84867183673 scopus 로고    scopus 로고
    • The prevention and treatment of missing data in clinical trials
    • R.J. Little, R. D'Agostino, M.L. Cohen The prevention and treatment of missing data in clinical trials N Engl J Med 367 2012 1355 1360
    • (2012) N Engl J Med , vol.367 , pp. 1355-1360
    • Little, R.J.1    D'Agostino, R.2    Cohen, M.L.3
  • 3
    • 84873095762 scopus 로고    scopus 로고
    • Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: Insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial
    • J. Butler, H. Subacius, M. Vaduganathan Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial J Am Coll Cardiol 61 2013 571 579
    • (2013) J Am Coll Cardiol , vol.61 , pp. 571-579
    • Butler, J.1    Subacius, H.2    Vaduganathan, M.3
  • 4
    • 33947713810 scopus 로고    scopus 로고
    • Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
    • M.A. Konstam, M. Gheorghiade, J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 2007 1319 1331
    • (2007) JAMA , vol.297 , pp. 1319-1331
    • Konstam, M.A.1    Gheorghiade, M.2    Burnett, Jr.J.C.3
  • 5
    • 0034820167 scopus 로고    scopus 로고
    • Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis Results from InTIME-II
    • R.P. Giugliano, J. Llevadot, R.G. Wilcox Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis Results from InTIME-II Eur Heart J 22 2001 1702 1715
    • (2001) Eur Heart J , vol.22 , pp. 1702-1715
    • Giugliano, R.P.1    Llevadot, J.2    Wilcox, R.G.3
  • 6
    • 84860390336 scopus 로고    scopus 로고
    • Influence of global region on outcomes in heart failure beta-blocker trials
    • C.M. O'Connor, M. Fiuzat, K. Swedberg Influence of global region on outcomes in heart failure beta-blocker trials J Am Coll Cardiol 58 2011 915 922
    • (2011) J Am Coll Cardiol , vol.58 , pp. 915-922
    • O'Connor, C.M.1    Fiuzat, M.2    Swedberg, K.3
  • 7
    • 0033981265 scopus 로고    scopus 로고
    • Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes Results from PURSUIT
    • K.M. Akkerhuis, J.W. Deckers, E. Boersma Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes Results from PURSUIT Eur Heart J 21 2000 371 381
    • (2000) Eur Heart J , vol.21 , pp. 371-381
    • Akkerhuis, K.M.1    Deckers, J.W.2    Boersma, E.3
  • 8
    • 71849108140 scopus 로고    scopus 로고
    • Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes
    • D.J. Kumbhani, C.P. Cannon, G.C. Fonarow Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes JAMA 302 2009 2207 2213
    • (2009) JAMA , vol.302 , pp. 2207-2213
    • Kumbhani, D.J.1    Cannon, C.P.2    Fonarow, G.C.3
  • 9
    • 20944445209 scopus 로고    scopus 로고
    • Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
    • M. Gheorghiade, C. Orlandi, J.C. Burnett Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Card Fail 11 2005 260 269
    • (2005) J Card Fail , vol.11 , pp. 260-269
    • Gheorghiade, M.1    Orlandi, C.2    Burnett, J.C.3
  • 10
    • 61449263596 scopus 로고    scopus 로고
    • Scientific evidence underlying the ACC/AHA clinical practice guidelines
    • P. Tricoci, J.M. Allen, J.M. Kramer, R.M. Califf, S.C. Smith Jr Scientific evidence underlying the ACC/AHA clinical practice guidelines JAMA 301 2009 831 841
    • (2009) JAMA , vol.301 , pp. 831-841
    • Tricoci, P.1    Allen, J.M.2    Kramer, J.M.3    Califf, R.M.4    Smith, Jr.S.C.5
  • 11
    • 79952260198 scopus 로고    scopus 로고
    • Diuretic strategies in patients with acute decompensated heart failure
    • G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
    • (2011) N Engl J Med , vol.364 , pp. 797-805
    • Felker, G.M.1    Lee, K.L.2    Bull, D.A.3
  • 12
    • 84866707415 scopus 로고    scopus 로고
    • Guided antithrombotic therapy: Current status and future research direction: Report on a national heart, lung and blood institute working group
    • V. Fuster, D.L. Bhatt, R.M. Califf Guided antithrombotic therapy: current status and future research direction: report on a national heart, lung and blood institute working group Circulation 126 2012 1645 1662
    • (2012) Circulation , vol.126 , pp. 1645-1662
    • Fuster, V.1    Bhatt, D.L.2    Califf, R.M.3
  • 13
    • 77953018430 scopus 로고    scopus 로고
    • Advancing the care of cardiac patients using registry data: Going where randomized clinical trials dare not
    • D.L. Bhatt Advancing the care of cardiac patients using registry data: going where randomized clinical trials dare not JAMA 303 2010 2188 2189
    • (2010) JAMA , vol.303 , pp. 2188-2189
    • Bhatt, D.L.1
  • 14
    • 33745644752 scopus 로고    scopus 로고
    • Interpreting observational studies - Look before you leap
    • A.A. Bavry, D.L. Bhatt Interpreting observational studies - look before you leap J Clin Epidemiol 59 2006 763 764
    • (2006) J Clin Epidemiol , vol.59 , pp. 763-764
    • Bavry, A.A.1    Bhatt, D.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.